Compass Therapeutics (CMPX) Long-Term Debt Issuances (2018 - 2021)

Compass Therapeutics (CMPX) posted Long-Term Debt Issuances of $3.8 million for Q4 2021, up 100.0% sequentially from $1.9 million in Q3 2021.

Compass Therapeutics (CMPX) Long-Term Debt Issuances (2018 - 2021) Analysis & Trends

Compass Therapeutics has reported Long-Term Debt Issuances for 4 years, with the latest figure at $3.8 million in Q4 2021.

Quarterly Long-Term Debt Issuances changed N/A year-over-year to $3.8 million in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $3.8 million (down 60.0% YoY) and the FY2021 annual result came in at $9.4 million, up 66.67% from the prior year.
Long-Term Debt Issuances improved to $3.8 million in Q4 2021 per CMPX's latest filing, from $1.9 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $3.8 million in Q3 2020 and troughed at $12500.0 in Q4 2018.
A 4-year average of $1.7 million and a median of $1.9 million in 2020 frame the typical range for Long-Term Debt Issuances.
The sharpest annual moves came in 2019 and 2021: Long-Term Debt Issuances surged 67.88% in 2019, then plunged 50.0% in 2021.
Over 4 years, Long-Term Debt Issuances stood at $12500.0 in 2018, then soared by 67.88% to $20985.0 in 2019, then jumped by 17769.91% to $3.8 million in 2020, then changed by 0.0% to $3.8 million in 2021.
According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $3.8 million, $1.9 million, and $1.9 million for Q4 2021, Q3 2021, and Q2 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-675,522.58
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Compass Therapeutics	405.20 Mn	405.20 Mn	-	-

Download Data